New evidence suggests there’s more to metastasis than MMPs, demanding a therapeutic rethink.
Jonathan James | | Quick Read
Metastasis is the most dangerous step in a cancer’s evolution, yet specific therapies intended to inhibit the process remain elusive. Scientists have long focused on inhibiting matrix metalloproteinases (MMPs) – a family of enzymes that are believed to aid cell migration by degrading the dense network of proteins – called the basement membrane – that surrounds human tissues. Now, a study reported in Developmental Cell suggests there may be far more to the story of metastasis than previously thought (1).
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!
- LC Kelley et al., “Adaptive F-actin Polymerization and Localized ATP Production Drive Basement Membrane Invasion in the Absence of MMPs.” Dev Cell, 18, 31084-6. [Epub ahead of print] (2019) PMID: 30686527